MENU
RLAY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Relay Therapeutics (RLAY) Ownership - Who owns Relay Therapeutics?

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients... Show more

Profile

Industry
N/A
Address
60 Hampshire Street
Phone
+1 617 370-8837
Employees
192
Web
https://www.relaytx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.24B
P/E Ratio
17.30
Total Cash
910.93M
Projected Growth
N/A
Total Debt
30.66M
Revenue
10.35M
Risk (Beta)
2.12
Dividend Yield
N/A
Total Cash/Share
4.16
Total Debt/Equity
N/A
Revenue/Share
0.06 USD as % of share price
View a ticker or compare two or three
RLAY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage precision medicines company, which focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets

Industry Biotechnology

Industry
N/A
Address
60 Hampshire Street
Phone
+1 617 370-8837
Employees
192
Web
https://www.relaytx.com
Who owns Relay Therapeutics? RLAY symbol Ownership - Tickeron.com